Visium Asset Management’s Aratana Therapeutics, Inc. PETX Stock Holding History

Visium Asset Management’s Portfolio PETX Stock Details PETX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-311,900	Closed	-$2.64M	–	944
2015 Q3	$2.64M	Sell	311,900 -1,936	-0.6%	-$32.8K	0.04%	400
2015 Q2	$4.75M	Sell	313,836 -1,100	-0.3%	-$15.9K	0.07%	295
2015 Q1	$5.04M	Sell	314,936 -60,200	-16%	-$1.07M	0.07%	260
2014 Q4	$6.68M	Buy	375,136 +220,000	+142%	+$2.74M	0.09%	192
2014 Q3	$1.56M	Hold	155,136	–	–	0.02%	506
2014 Q2	$2.42M	Sell	155,136 -100	-0.1%	-$1.42K	0.04%	366
2014 Q1	$2.88M	Buy	+155,236	New	+$3.11M	0.05%	323

Other funds holding PETX

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Visium Asset Management's PETX Position: Q4 2015 in Review

Visium Asset Management sold out of Aratana Therapeutics, Inc. (PETX) in Q4 2015, closing a stake of 311,900 shares — an estimated $2.64M sold.

Visium Asset Management first reported a position in PETX in Q1 2014 and held it in 7 quarters. The position peaked at $6.68M in Q4 2014. 98 funds tracked by Wall St. Rank hold PETX as of Q4 2015.

Visium Asset Management reported no remaining Aratana Therapeutics, Inc. position as of Q4 2015 after selling out during the quarter.
Visium Asset Management sold 311,900 Aratana Therapeutics, Inc. shares in Q4 2015, an estimated $2.64M.
Visium Asset Management first reported a position in Aratana Therapeutics, Inc. in Q1 2014 and held it in 7 quarters.
Visium Asset Management's Aratana Therapeutics, Inc. position peaked at $6.68M in Q4 2014.
98 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q4 2015.

Based on Visium Asset Management's 13F filing for Q4 2015, filed 12 Feb 2016.